Ayr Wellness Inc.

General ticker "AYRWF" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $26.3M (TTM average)

Ayr Wellness Inc. does not follow the US Stock Market performance with the rate: -17.5%.

Estimated limits based on current volatility of 22.8%: low 0.01$, high 0.01$

Factors to consider:

  • Current price 95.2% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.27$, 0.95$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.23$, 0.75$]

Financial Metrics affecting the AYRWF estimates:

  • Positive: with PPE of -0.3 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Positive: Operating cash flow per share per price, % of 20.68 > 13.24
  • Positive: 18.93 < Shareholder equity ratio, % of 29.90 <= 41.86
  • Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15

Similar symbols

Short-term AYRWF quotes

Long-term AYRWF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $463.63MM $463.63MM
Operating Expenses $500.84MM $624.62MM
Operating Income $-37.21MM $-160.99MM
Non-Operating Income $-8.54MM $-158.10MM
Interest Expense $39.40MM $78.26MM
Income(Loss) $-45.76MM $-319.09MM
Taxes $47.39MM $43.27MM
Profit(Loss)* $-272.43MM $-359.31MM
Stockholders Equity $581.78MM $379.53MM
Inventory $105.82MM $112.56MM
Assets $1,459.86MM $1,269.16MM
Operating Cash Flow $27.16MM $9.63MM
Capital expenditure $39.60MM $24.77MM
Investing Cash Flow $-24.15MM $-21.81MM
Financing Cash Flow $-32.89MM $-3.10MM
Earnings Per Share** $-3.68 $-3.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.